This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This capability is attracting pharmaceutical and life science companies, health care providers and research organizations to take a closer look at Seqster’s offering. In summing up the patient-centered interoperability goal, Ardy summarized: “We’ve created the Mint.com of health data.”
Each year, ECRI (the ECRI Institute) publishes an annual report on the Top 10 Patient Safety Concerns for the year. The 2025 list was published today. My read of it is that most of these risks have to do with what I’ve been referring to as the Human OS, the Human Operating System, in my talks and teachings.
To innovate more, and more quickly, across the entire ecosystem of health — in government policies, pharmaceutical innovations, and technology developments. To scale what works, based on evidence and proven interventions — which depends on our reducing biases in our assumptions, models and strategies.
The infection rate is once again trending up, presumably due to a combination of factors including a dramatic reduction in demand for new vaccinations, the rapid spread of the more infectious Delta variant in the U.S., as well as the reduction in mitigation measures.” ” .
Capgemini offers recommendations to providers, pharmaceutical companies, and medical device manufacturers to tap opportunities outside of inpatient settings and, increasingly, to the home and digital device. These trends point to more care being demanded by patients outside of the legacy care system, at home and via more virtual platforms.
health care system, especially laying bare inequities and inertia in American health care, explained in The Progress We Need: Ten Health Care Imperatives for the Decade Ahead from Manatt Health. The coronavirus pandemic has exposed major weaknesses in the U.S.
The idea of health care consumerism isn’t just an American discussion, Deloitte points out in its 2019 global survey of healthcare consumers report, A consumer-centered future of health.
Telehealth has increased access to mental health services, I’ve highlighted this Mental Illness Awareness Week here in Health Populi. But telehealth has also emerged as a preferred channel for routine health care services, we learn from J.D. Power’s 2022 Telehealth Satisfaction Study.
Lululemon has published the 2024 Global Well-Being Report , a study into peoples’ perspectives on their personal health from the company best known for athleisure wear and self-care. This year’s report is titled, The Pressure to Be Well. That pressure is coming from peoples’ experiencing “well-being burnout.”
Here’s a link to the 30-minute conversation, where Marc combed through the over 500 endnotes from HealthConsuming ‘s appendix to explore the patient as the new health care payor, the Amazon prime-ing of people, and prospects for social determinants of health to bolster medicines “beyond the pill.”.
And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. Patients knew this – PLM was emphatic about transparency in its community and the company never hid what they were doing with people’s data.
Foogal, a recipe app designed to support patients’ healthy cooking and eating, launched on 24th March. In its initial version, Foogal addresses several specific diet paradigms: for patients demanding a wellness protocol, an autoimmune protocol, or wanting to address insulin resistance.
This only accelerated during the coronavirus pandemic, and this time around, bolstered by digital health tools and access to broadband unavailable 14 years ago. Consumers are excited about connectedhealth care , the Trusted Future study bullishly reports.
Hims & Hers announced a new service offering for health consumers and clinicians concerned about heart health called Heart Health by Hims. This is Hims & Hers’ first foray into cardiovascular health, working in collaboration with the American College of Cardiology (ACC).
health care economics, patients are now payors as health consumers with more financial skin in paying medical bills. As consumers, people have great expectations from the organizations on the supply side of health care — providers (hospitals and doctors), health insurance plans, pharma and medical device companies.
On the prescription drug front, Eli Lilly pioneering a DTC channel for consumers to access their product, Zepbound, directly from the manufacturer a novel approach for a pharmaceutical company to implement via their LillyDirect platform. Wishing everyone well on your individual and collective journeys in 2025.
Health Populi’s Hot Points: In challenging moments like this COVID-19 pandemic threat, we look for gifts of learning and opportunity — and this is one where the case for telehealth and broadband connectivity comes to the fore. TIME magazine covered this yesterday in a mainstream media story.
During the hearing, Senator Patty Murray (D-WA) challenged Azar, “As a pharmaceutical executive, you raised drug prices year after year. Note that Azar was once President of Eli Lilly, among the world’s largest pharma companies and marketer of products that treat diabetes, among other conditions.
The new year will see a “looming tsunami” of high prices in healthcare, regulation trumping health reform, more business deals reshaping the health/care industry landscape, and patients growing do-it-yourself care muscles, according to Top health industry issues of 2020: Will digital start to show an ROI from the PwC Health Research Institute. (..)
Uncertainties and grey areas prevail, with very shaky financial markets domestically and globally — all impacting various segments of health care systems — from hospitals and health plans to pharmaceuticals and medical devices, clinical labor markets and researchers (namely – might the U.S.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content